Converting ginsenosides from stems and leaves of

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

1. The rise of dehydrated ginsenosides: phytochemistry and pharmacology.Journal of advanced research · 2026
   Review
2. Biotransformation approach to produce rare ginsenosides F1, compound Mc1, and Rd2 from major ginsenosides.Archives of microbiology · 2024
   Article
3. Analysis of metabolites and metabolism-mediated biological activity assessment of ginsenosides on microfluidic co-culture system.Frontiers in pharmacology · 2023
   Article
4. Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations.Nanomaterials (Basel, Switzerland) · 2022
   Review
5. Characterization of a Novel Ginsenoside MT1 Produced by an Enzymatic Transrhamnosylation of Protopanaxatriol-Type Ginsenosides Re.Biomolecules · 2020
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

9 authors at 2 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract